Isolated Gamma‐Glutamyltransferase Elevation During Statin Therapy: A Diagnostic Pitfall and a Stepwise Management Framework to Prevent Unnecessary Discontinuation
Clinical Case Reports · 2026-06 · 14 (6)
DOI: 10.1002/ccr3.72871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 06.06.2026. Verfasst von Jun Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Santai Hospital Affiliated to North Sichuan Medical College Mianyang Sichuan Province China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The management of patients with isolated gamma‐glutamyltransferase (GGT) elevation during statin therapy remains a common clinical dilemma due to the unclear relevance to hepatotoxicity. We report a case of a patient with coronary artery disease who developed persistent isolated GGT elevation (> 100 U/L) while on atorvastatin, with normal alanine and aspartate aminotransferase levels. Critically, the elevated GGT persisted after statin withdrawal, and a comprehensive workup revealed uncontrolled cardiometabolic risk factors. We conclude that isolated GGT elevation in this context is more likely a biomarker of underlying cardiovascular risk than of statin‐induced liver injury. Based on this case analysis, we propose a stepwise decision framework to guide evaluation and management in such scenarios. Through literature review and case analysis, we conclude that isolated GGT elevation is not a reliable indicator of statin hepatotoxicity and may be associated with cardiovascular risk. Therefore, clinicians should not hastily discontinue statins. Instead, a comprehensive assessment should be initiated to identify potential causes and personalize treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Santai Hospital Affiliated to North Sichuan Medical College Mianyang Sichuan Province China.
ORCID-Profile: Jun Yang
Zitieren
APA
Yang, J., He, Y., & Zhang, Z. (2026). Isolated Gamma‐Glutamyltransferase Elevation During Statin Therapy: A Diagnostic Pitfall and a Stepwise Management Framework to Prevent Unnecessary Discontinuation. Clinical Case Reports, 14(6). https://doi.org/10.1002/ccr3.72871
Vancouver
Yang J, He Y, Zhang Z. Isolated Gamma‐Glutamyltransferase Elevation During Statin Therapy: A Diagnostic Pitfall and a Stepwise Management Framework to Prevent Unnecessary Discontinuation. Clinical Case Reports. 2026;14(6). doi:10.1002/ccr3.72871
BibTeX
@article{Yang2026,
author = {Yang, Jun and He, Yanling and Zhang, Zhengyong},
title = {Isolated Gamma‐Glutamyltransferase Elevation During Statin Therapy: A Diagnostic Pitfall and a Stepwise Management Framework to Prevent Unnecessary Discontinuation},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {6},
doi = {10.1002/ccr3.72871}
}
EUVIMED